The Manta vascular closure device, which has received CE Mark, is specifically designed for closure of large bore arteriotomies after procedures utilizing devices or sheaths ranging in size from 10F to 18F (with maximum outer diameters up to 25F).
In the recent CE Mark study, the device is claimed to have showed rapid and reliable hemostasis with its resorbable collagen-based technology and complication rates that were non-inferior to surgical and suture-based closure methods, Teleflex noted.
The Manta vascular closure device is not approved for sale in the US.
Teleflex president and CEO Liam Kelly said: “We are very excited to announce this acquisition, which expands our presence in the structural heart and endovascular aneurysm repair markets.”
“The Manta vascular closure device represents a truly innovative solution to address closure-related complications and high costs associated with many large and rapidly growing interventional procedure categories, such as transcatheter aortic valve replacement, endovascular aneurysm repair and ventricular assist device implantation.”
Teleflex stated that physician adoption of the Manta device across international markets has been significant with more than 8,100 procedures completed, in the EU.
The premarket approval from the US FDA for Manta vascular closure device is expected next year.
Essential Medical was founded in 2010 by Greg Walters and Gary Roubin. The company aims to develop and commercialize new vascular closure devices for femoral punctures following diagnostic and interventional cardiac catheterization procedures.
Walters said: “The combination of Teleflex and Essential Medical provides an excellent opportunity to maximize physician and patient access to the MANTA Vascular Closure Device.
“We are delighted to become an important part of Teleflex’s interventional cardiology business.”
Teleflex is a Wayne, Pennsylvania-headquartered medical devices company. It has a portfolio of solutions in fields including vascular and interventional access, surgical, anesthesia, cardiac care, urology, emergency medicine and respiratory care.
